Bessemer Group’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History

Bessemer Group’s Portfolio MBVX Stock Details MBVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-30	Closed	–	–	2106
2018 Q4	$0	Buy	+30	New	–	﹤0.01%	2134

Other funds holding MBVX

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Bessemer Group's MBVX Position: Q1 2019 in Review

Bessemer Group sold out of MABVAX THERAPEUTICS HLDGS INC (MBVX) in Q1 2019, closing a stake of 30 shares.

Bessemer Group first reported a position in MBVX in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 1 fund tracked by Wall St. Rank holds MBVX as of Q1 2019.

Bessemer Group reported no remaining MABVAX THERAPEUTICS HLDGS INC position as of Q1 2019 after selling out during the quarter.
Bessemer Group sold 30 MABVAX THERAPEUTICS HLDGS INC shares in Q1 2019.
Bessemer Group first reported a position in MABVAX THERAPEUTICS HLDGS INC in Q4 2018 and held it in 1 quarter.
Bessemer Group's MABVAX THERAPEUTICS HLDGS INC position peaked at $0 in Q4 2018.
1 fund tracked by Wall St. Rank held MABVAX THERAPEUTICS HLDGS INC as of Q1 2019.

Based on Bessemer Group's 13F filing for Q1 2019, filed 13 May 2019.